Sommario

• • ·Editorial Board

    Articolo :100291

    
• • ·Content

    Articolo :100292

    

• Editorials

  • ·Astrocytes provide a unique biomarker for Alzheimer’s and other pathologies

    Articolo :100233

    Eric Siemers

    Mappa Mappa
  • ·Breaking Barriers: Delivering Therapeutics to the Brain in Alzheimer’s Disease

    Articolo :100229

    Bart De Strooper, Philip Scheltens, Stephen Salloway

    Mappa Mappa
  • ·Exercise for dementia prevention: Evidence for a flexible prescription

    Articolo :100249

    Mikel Izquierdo

    Mappa Mappa
  • ·Physical activity and Alzheimer’s disease: a call for evidence incorporation

    Articolo :100225

    Juan Luis Sánchez-Sánchez, Philipe de Souto Barreto

    Mappa Mappa  
  • ·Serum BDNF and progression to MCI in cognitively normal older adults A prospective cohort study

    Articolo :100254

    Gary A. Rosenberg

    Mappa Mappa

• Original article

  • ·Utility of plasma GFAP as a secondary endpoint for clinical trials in Alzheimer’s disease

    Articolo :100205

    Sarah Abbas, Pamela C. L Ferreira, Bruna Bellaver, Guilherme Povala, Francieli Rohden, Cristiano Schaffer Aguzzoli, Hussein Zalzale, João Pedro Ferrari-Souza, Douglas T. Leffa, Firoza Z. Lussier, Carolina Soares, Guilherme Bauer-Negrini, Markley Silva Oliveira-Junior, Matheus Scarpatto Rodrigues, Pampa Saha, Emma Ruppert, Marina Scop Medeiros, Cécile Tissot, Joseph Therriault, Nesrine Rahmouni, Stijn Servaes, Andrea L. Benedet, Nicholas J. Ashton, Dana L. Tudorascu, Serge Gauthier, Helmet Karim, Chang Hyung Hong, Hyun Woong Roh, Eduardo R Zimmer, Thomas K. Karikari, Henrik Zetterberg, Kaj Blennow, Anum Saeed, Sang Joon Son, Pedro Rosa-Neto, Tharick Pascoal, for Alzheimer’s Disease Neuroimaging Initiative

    Riassunto Riassunto Mappa Mappa   

• Review

  • ·Drug delivery strategies to cross the blood-brain barrier in Alzheimer’s disease: a comprehensive review on three promising strategies

    Articolo :100204

    Lotte A. de Koning, Daniel A. Vazquez-Matias, Wissam Beaino, Daniëlle J. Vugts, Guus A.M.S. van Dongen, Wiesje M. van der Flier, Mario Ries, Dannis G. van Vuurden, Everard G.B. Vijverberg, Elsmarieke van de Giessen

    Riassunto Riassunto Mappa Mappa   

• Original articles

  • ·Dose- and pattern- physical activity is associated with lower risk of dementia

    Articolo :100223

    Yan Wang, Fangyu Li, Shuman Cao, Jianping Jia

    Riassunto Riassunto Mappa Mappa   
  • ·Lifetime walking and Alzheimer’s pathology: A longitudinal study in older adults

    Articolo :100203

    Jee Wook Kim, Musung Keum, Min Soo Byun, Dahyun Yi, So Yeon Jeon, Joon Hyung Jung, Nayeong Kong, Yoon Young Chang, Gijung Jung, Hyejin Ahn, Jun-Young Lee, Koung Mi Kang, Chul-Ho Sohn, Yun-Sang Lee, Yu Kyeong Kim, Dong Young Lee, KBASE Research Group

    Riassunto Riassunto Mappa Mappa   
  • ·Serum BDNF and progression to MCI in cognitively normal older adults: A prospective cohort study

    Articolo :100210

    Kyungtae Kim, Min Soo Byun, Dahyun Yi, Joon Hyung Jung, Bo Kyung Sohn, Gijung Jung, Hyejin Ahn, Jun-Young Lee, Yun-Sang Lee, Yu Kyeong Kim, Kwangsik Nho, Dong Young Lee, for the KBASE Research Group

    Riassunto Riassunto Mappa Mappa   

• Review

  • ·Advancing the science of recruitment for Alzheimer’s clinical trials: Challenges and opportunities

    Articolo :100230

    Paul Aisen, Desi Peneva, Maria-Alice Manetas, Mireille Jacobson, Dana Goldman, Niranjan Bose, Phyllis Barkman Ferrell, VK Vu, Rema Raman

    Riassunto Riassunto Mappa Mappa

• Original articles

  • ·Plasma p-tau217 predicting brain-wide tau accumulation in preclinical AD

    Articolo :100252

    Hasom Moon, Xi Chen, Alzheimer’s Disease Neuroimaging Initiative

    Riassunto Riassunto Mappa Mappa   
  • ·Lower baseline amyloid beta burden is associated with greater percent of amyloid beta positron emission tomography reduction and better clinical outcomes in the aducanumab Phase 3 trials ENGAGE and EMERGE in early Alzheimer's disease

    Articolo :100202

    Jackson Burton, Holly M. Brothers, R. Matthew Hutchison, Jennifer Murphy, Tao Sun, Gersham Dent, Gioacchino Curiale, Ken Kowalski

    Riassunto Riassunto Mappa Mappa   
  • ·Estimation of the value-based price of a blood test for Alzheimer’s disease pathology in primary and specialty care in the U.S.

    Articolo :100219

    Soeren Mattke, Jiahe Chen, Mark Hanson, Kim G. Johnson, Cara Leahy, David A. Merrill, Victoria Shada, Jorge G. Ruiz

    Riassunto Riassunto Mappa Mappa   
  • ·Using machine learning and electronic health record (EHR) data for the early prediction of Alzheimer's Disease and Related Dementias

    Articolo :100169

    Sonia Akter, Zhandi Liu, Eduardo J. Simoes, Praveen Rao

    Riassunto Riassunto Mappa Mappa  

• Review

  • ·Comparative efficacy of cognitive training modalities in cognitive impairment: A systematic review and network meta-analysis

    Articolo :100207

    Li-bing Liang, Shan Wang, Kun-peng Li, Cai-qin Wu

    Riassunto Riassunto Mappa Mappa   

• Original articles

  • ·The patient pathway for mild cognitive impairment due to Alzheimer’s disease in Asia: Current practices, barriers, and expert recommendations for optimization

    Articolo :100215

    Seong Hye Choi, SangYun Kim, Paulus Anam Ong, Ai Vyrn Chin, Jacqueline Dominguez, Christopher Li-Hsian Chen, Vorapun Senanarong, Chaur-Jong Hu, Manjari Tripathi, Vincent Mok, Gandan Jiang, Amitabh Dash

    Riassunto Riassunto Mappa Mappa   
  • ·Salivary levels of amyloid beta reflect brain amyloid beta burden in cognitively-normal older adults

    Articolo :100216

    Alison R. Bamford, Jenna N. Adams, Soyun Kim, Lisa M. Taylor, Nandita Tuteja, Liv C. McMillan, Negin Sattari, Ivy Y. Chen, Miranda G. Chappel-Farley, Yuritza Escalante, Alyssa L. Lawrence, Novelle J. Meza, Destiny E. Berisha, Abhishek Dave, Rond Malhas, Mark Mapstone, Bryce A. Mander, Michael A. Yassa, Elizabeth A. Thomas

    Riassunto Riassunto Mappa Mappa   
  • ·Association of multimorbidity and disease clusters with neuroimaging and cognitive outcomes in UK Biobank

    Articolo :100208

    Shehab Uddin Al Abid, Catherine M Calvin, Danial Qureshi, Michele Veldsman, Elżbieta Kuźma, Thomas J. Littlejohns

    Riassunto Riassunto Mappa Mappa   
  • ·A six-year risk assessment for dementia and Alzheimer's disease in the general population through immunoprecipitation-mass spectrometry plasma amyloid quantification

    Articolo :100186

    Germain U. Busto, Christophe Hirtz, Isabelle Carriere, Karim Bennys, Laure-Anne Gutierrez, Jana Kindermans, Catherine Helmer, Audrey Gabelle, Sylvain Lehmann, Claudine Berr

    Riassunto Riassunto Mappa Mappa   

• Review

  • ·Brain photobiomodulation: a potential treatment in Alzheimer’s and Parkinson’s diseases

    Articolo :100185

    Guillaume Blivet, Benjamin Touchon, Hugo Cavadore, Sara Guillemin, Frédéric Pain, Michael Weiner, Marwan Sabbagh, Cécile Moro, Jacques Touchon

    Riassunto Riassunto Mappa Mappa

• Original articles

  • ·Value of blood neural cell-derived small extracellular vesicles in the diagnosis and prediction of Alzheimer's disease: A systematic review

    Articolo :100193

    Weibing Pan, Yu Teng, Xiaowan Han, Shaojiao Liu, Xingxue Pang, Lei Wang, Mingjing Zhao

    Riassunto Riassunto Mappa Mappa   
  • ·Association of the difference between cystatin C- and creatinine-based estimated glomerular filtration rate with cerebral small vessel disease: A large prospective cohort study

    Articolo :100190

    Zhiming Li, Fei Wang, Jincheng Liu, Benbo Xiong, Han Wang, Zijie Wang, Xiao Hu, Qi Li

    Riassunto Riassunto Mappa Mappa   
  • ·Poor glymphatic function is associated with mild cognitive impairment and its progression to Alzheimer's disease: A DTI-ALPS study

    Articolo :100156

    Cuiping Bao, Hongbin Luo, Jiao Wang, Xuehuan Liu, Yiming Li, Jun Yang, Chong Chen, Rongrong Yang, Weili Ba, Xinying Lian, Michelle Dunk, Jun Liu, Weili Xu

    Riassunto Riassunto Mappa Mappa   
  • ·Phenotypic alterations in peripheral blood B Lymphocytes of patients with Alzheimer's Disease

    Articolo :100135

    Meng-Ting Wang, Ye-Ran Wang, Gui-Hua Zeng, Xiao-Qin Zeng, Zhang-Cheng Fei, Jia Chen, Jin Zhou, Xin-Peng Li, Zhi-Qiang Xu, Yan-Jiang Wang, Yu-Hui Liu

    Riassunto Riassunto Mappa Mappa   

• Review

  • ·Multimorbidity and risk of dementia: A systematic review and meta-analysis of longitudinal cohort studies

    Articolo :100164

    Yaguan Zhou, Yating You, Yuting Zhang, Yue Zhang, Changzheng Yuan, Xiaolin Xu

    Riassunto Riassunto Mappa Mappa   

• Original article

  • ·Fingolimod ameliorates amyloid deposition and neurodegeneration in APP/PS1 mouse model of Alzheimer's disease

    Articolo :100131

    Meng-Ting Wang, Zi-Cheng Hu, Yang Xiang, Xiao-Qin Zeng, Zhang-Cheng Fei, Jia Chen, Xin-Peng Li, Yu-Peng Zhu, Jun Wang, Yan-Jiang Wang, Zhi-Qiang Xu, Yu-Hui Liu

    Riassunto Riassunto Mappa Mappa  

• Letters to the editor

  • ·Comment on "Hearing loss, diet, and cognitive decline: interconnections for dementia prevention"

    Articolo :100189

    Cuiqing Zhao, Jian Gong, Jia Huang

    Mappa Mappa
  • ·Response to letter regarding “hearing loss, diet, and cognitive decline: Interconnections for dementia prevention”

    Articolo :100188

    Xiaoran Liu, Uzma S. Akhtar

    Mappa Mappa
  • ·Monitoring of amyloid related imaging abnormalities: SWI vs T2*-GRE

    Articolo :100220

    Diana M. Sima, Thanh Vân Phan, Ana M. Franceschi, Wende N. Gibbs, Frederik Barkhof, Philip Scheltens, Stephen Salloway, Jeffrey Cummings, Wim Van Hecke, Dirk Smeets

    Riassunto Riassunto Mappa Mappa

• Errata

  • ·Erratum to “INTERCEPT-AD, a phase 1 study of intravenous sabirnetug in participants with mild cognitive impairment or mild dementia due to Alzheimer's disease” [J Prev Alzheimers Dis 2025;12(1): 100005.]

    Articolo :100213

    Eric Siemers, Todd Feaster, Gopalan Sethuraman, Karen Sundell, Vladimir Skljarevski, Erika N. Cline, Hao Zhang, Jasna Jerecic, Lawrence S. Honig, Stephen Salloway, Reisa Sperling, Mirjam N. Trame, Michael G. Dodds, Kimball Johnson

    
  • ·Erratum to “Biofluid biomarker changes following treatment with sabirnetug (ACU193) in INTERCEPT-AD, a phase 1 trial in early Alzheimer's disease” [J Prev Alzheimers Dis 2025;12(4): 100082]

    Articolo :100217

    Erika N. Cline, Daniel Antwi-Berko, Karen Sundell, Elizabeth Johnson, Maddelyn Hyland, Hao Zhang, Hugo Vanderstichele, June Kaplow, Robert A. Dean, Erik Stoops, Eugeen Vanmechelen, Marleen J.A. Koel-Simmelink, Charlotte E. Teunissen, Gopalan Sethuraman, Todd Feaster, Eric Siemers, Jasna Jerecic

    Mappa Mappa